Meet IHMA at the 2024 ECCMID conference in Barcelona from April 27 to 30, 2024. Rendez-vous at the booth Stand E67 !
Based on the Monthey-site of BioArk, the company IHMA is specialized in infectious diseases & offer the most comprehensive offering of products and services for developing and marketing antimicrobial agents.
From April 27 to 30, 2024, IHMA will be presenting 38 scientific posters during this event, and encourage you to come by to view and discuss these presentations.
IHMA will also be exhibiting at booth E67 and welcomes the opportunity to meet and speak with you.
About IHMA Capabilities
IHMA remains at the forefront in the battle against antimicrobial resistance, diligently supporting our clients throughout their studies. Through IHMA’s extensive knowledge and support, we strive to promote and advance the development of effective antimicrobials.
IHMA offers an extensive array of studies and activities designed to assess and validate the safety and efficacy of antimicrobials. Our services offer a robust foundation to ensure the viability and reliability of antimicrobial treatments. These include though are not limited to:
- Preclinical characterization of new antimicrobials
- MIC Profiling
- Checkerboard Assays
- Resistance Development
- Time-Kill Kinetics (TKK)
- CLSI Tier I & II Studies
- Global laboratory services for all phases of clinical trials (Phase 1 thru 4)
- Global AntiMicrobial Resistance (AMR) surveillance (bacterial and fungal)
- Molecular characterization of antimicrobial resistance genes
- Molecular characterization of infectious disease agents
- New therapeutic approaches (bacteriophage, vaccine, etc.)
- In vitro diagnostic device studies
